A Non-D2-Receptor-Binding Drug for the Treatment of Schizophrenia
Otsuka Pharmaceutical Development & Commercialization, Inc.
Kenneth S Koblan; Justine Kent; Seth C Hopkins; John H Krystal; Hailong Cheng; Robert Goldman; Antony Loebel